Report Detail

Global (United States, European Union and China) Gastro Esophageal Reflux Disease Drug and Devices Market Research Report 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Medigus Ultrasonic Surgical Endostapler
      • 1.3.3 LINX Management System
      • 1.3.4 Stretta Therapy
      • 1.3.5 Bravo Reflux Testing System
      • 1.3.6 Digitrapper Reflux Testing System
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Value 2014-2025
      • 2.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production 2014-2025
      • 2.1.3 Global Gastro Esophageal Reflux Disease Drug and Devices Capacity 2014-2025
      • 2.1.4 Global Gastro Esophageal Reflux Disease Drug and Devices Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size CAGR of Key Regions
      • 2.2.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Capacity by Manufacturers
      • 3.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Gastro Esophageal Reflux Disease Drug and Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Gastro Esophageal Reflux Disease Drug and Devices Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Gastro Esophageal Reflux Disease Drug and Devices Market Concentration Ratio (CR5 and HHI)
    • 3.3 Gastro Esophageal Reflux Disease Drug and Devices Price by Manufacturers
    • 3.4 Key Manufacturers Gastro Esophageal Reflux Disease Drug and Devices Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Gastro Esophageal Reflux Disease Drug and Devices Market
    • 3.6 Key Manufacturers Gastro Esophageal Reflux Disease Drug and Devices Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Medigus Ultrasonic Surgical Endostapler Production and Production Value (2014-2019)
      • 4.1.2 LINX Management System Production and Production Value (2014-2019)
      • 4.1.3 Stretta Therapy Production and Production Value (2014-2019)
      • 4.1.4 Bravo Reflux Testing System Production and Production Value (2014-2019)
      • 4.1.5 Digitrapper Reflux Testing System Production and Production Value (2014-2019)
      • 4.1.6 Others Production and Production Value (2014-2019)
    • 4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production Market Share by Type
    • 4.3 Global Gastro Esophageal Reflux Disease Drug and Devices Production Value Market Share by Type
    • 4.4 Gastro Esophageal Reflux Disease Drug and Devices Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Application

    6 Production by Regions

    • 6.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production (History Data) by Regions 2014-2019
    • 6.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate 2014-2019
      • 6.3.2 United States Gastro Esophageal Reflux Disease Drug and Devices Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Gastro Esophageal Reflux Disease Drug and Devices Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate 2014-2019
      • 6.4.2 European Union Gastro Esophageal Reflux Disease Drug and Devices Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Gastro Esophageal Reflux Disease Drug and Devices Import & Export
    • 6.5 China
      • 6.5.1 China Gastro Esophageal Reflux Disease Drug and Devices Production Growth Rate 2014-2019
      • 6.5.2 China Gastro Esophageal Reflux Disease Drug and Devices Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Gastro Esophageal Reflux Disease Drug and Devices Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Gastro Esophageal Reflux Disease Drug and Devices Consumption by Regions

    • 7.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Gastro Esophageal Reflux Disease Drug and Devices Consumption by Type
      • 7.2.2 United States Gastro Esophageal Reflux Disease Drug and Devices Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Gastro Esophageal Reflux Disease Drug and Devices Consumption by Type
      • 7.3.2 European Union Gastro Esophageal Reflux Disease Drug and Devices Consumption by Application
    • 7.4 China
      • 7.4.1 China Gastro Esophageal Reflux Disease Drug and Devices Consumption by Type
      • 7.4.2 China Gastro Esophageal Reflux Disease Drug and Devices Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Gastro Esophageal Reflux Disease Drug and Devices Consumption by Type
      • 7.5.2 Rest of World Gastro Esophageal Reflux Disease Drug and Devices Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 AstraZeneca PLC
      • 8.1.1 AstraZeneca PLC Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.1.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.1.5 AstraZeneca PLC Recent Development
    • 8.2 Pfizer Inc.
      • 8.2.1 Pfizer Inc. Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.2.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.2.5 Pfizer Inc. Recent Development
    • 8.3 Johnson & Johnson
      • 8.3.1 Johnson & Johnson Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.3.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.3.5 Johnson & Johnson Recent Development
    • 8.4 Novartis AG
      • 8.4.1 Novartis AG Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.4.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.4.5 Novartis AG Recent Development
    • 8.5 GlaxoSmithKline Plc
      • 8.5.1 GlaxoSmithKline Plc Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.5.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.5.5 GlaxoSmithKline Plc Recent Development
    • 8.6 Merck & CO., Inc.
      • 8.6.1 Merck & CO., Inc. Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.6.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.6.5 Merck & CO., Inc. Recent Development
    • 8.7 Takeda Pharmaceutical Company Limited
      • 8.7.1 Takeda Pharmaceutical Company Limited Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.7.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.7.5 Takeda Pharmaceutical Company Limited Recent Development
    • 8.8 Boston Scientific Corporation
      • 8.8.1 Boston Scientific Corporation Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.8.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.8.5 Boston Scientific Corporation Recent Development
    • 8.9 Ironwood Pharmaceuticals, Inc.
      • 8.9.1 Ironwood Pharmaceuticals, Inc. Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.9.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.9.5 Ironwood Pharmaceuticals, Inc. Recent Development
    • 8.10 Valeant Pharmaceuticals International, Inc.
      • 8.10.1 Valeant Pharmaceuticals International, Inc. Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Gastro Esophageal Reflux Disease Drug and Devices
      • 8.10.4 Gastro Esophageal Reflux Disease Drug and Devices Product Introduction
      • 8.10.5 Valeant Pharmaceuticals International, Inc. Recent Development
    • 8.11 Cempra Inc.
    • 8.12 Medtronic Inc.
    • 8.13 Medigus Ltd.
    • 8.14 Teva Pharmaceuticals Industries Limited.
    • 8.15 EndoGastric Solutions Inc.
    • 8.16 EndoStim Inc.
    • 8.17 Jeil pharmaceutical Co. Ltd.
    • 8.18 Mederi Therapeutics Inc.
    • 8.19 Torax Medical

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Gastro Esophageal Reflux Disease Drug and Devices Production Forecast by Type
      • 9.7.2 Global Gastro Esophageal Reflux Disease Drug and Devices Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Gastro Esophageal Reflux Disease Drug and Devices Sales Channels
      • 10.2.2 Gastro Esophageal Reflux Disease Drug and Devices Distributors
    • 10.3 Gastro Esophageal Reflux Disease Drug and Devices Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Gastro Esophageal Reflux Disease Drug and Devices is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gastro Esophageal Reflux Disease Drug and Devices.

      This report studies the global market size of Gastro Esophageal Reflux Disease Drug and Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Gastro Esophageal Reflux Disease Drug and Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      AstraZeneca PLC
      Pfizer Inc.
      Johnson & Johnson
      Novartis AG
      GlaxoSmithKline Plc
      Merck & CO., Inc.
      Takeda Pharmaceutical Company Limited
      Boston Scientific Corporation
      Ironwood Pharmaceuticals, Inc.
      Valeant Pharmaceuticals International, Inc.
      Cempra Inc.
      Medtronic Inc.
      Medigus Ltd.
      Teva Pharmaceuticals Industries Limited.
      EndoGastric Solutions Inc.
      EndoStim Inc.
      Jeil pharmaceutical Co. Ltd.
      Mederi Therapeutics Inc.
      Torax Medical

      Market Segment by Product Type
      Medigus Ultrasonic Surgical Endostapler
      LINX Management System
      Stretta Therapy
      Bravo Reflux Testing System
      Digitrapper Reflux Testing System
      Others

      Market Segment by Application
      Hospitals
      Clinics
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Gastro Esophageal Reflux Disease Drug and Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Gastro Esophageal Reflux Disease Drug and Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Gastro Esophageal Reflux Disease Drug and Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Gastro Esophageal Reflux Disease Drug and Devices . Industry analysis & Market Report on Gastro Esophageal Reflux Disease Drug and Devices is a syndicated market report, published as Global (United States, European Union and China) Gastro Esophageal Reflux Disease Drug and Devices Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Gastro Esophageal Reflux Disease Drug and Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,638.65
      3,957.97
      5,277.30
      2,921.93
      4,382.89
      5,843.85
      354,725.44
      532,088.16
      709,450.88
      225,558.06
      338,337.08
      451,116.11
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report